• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Journal of the Canadian Association of Gastroenterology

    Journal of the Canadian Association of Gastroenterology

    JournalISSN 2515-2084eISSN 2515-2092

    年发文量

    研究主题

    论文(3434)

    排序
    1Implementation of Intestinal Ultrasound in Canadian Inflammatory Bowel Disease Care: Perspectives from a National Expert Roundtable
    Kerri Novak, Matt Smyth, Siwar Al-Bashir,Jean-Frederic LeBlanc,Michael Stewart

    Abstract Intestinal ultrasound (IUS) is increasingly used as a point-of-care tool during routine follow-up care for the assessment and longitudinal monitoring of inflammatory bowel disease (IBD). Although its clinical advantages are well established, implementation across Canada remains uneven. Implementation in Canada has been shaped by variable training capacity, infrastructure, reimbursement, workflow, and provincial health-system organization. A virtual national roundtable of experts was convened to explore the practical role of IUS in contemporary Canadian IBD care, identify barriers to wider adoption, and define priorities for future implementation. The panel included adult and pediatric gastroenterologists from multiple Canadian provinces from diverse practice environments. The discussion was guided by 3 domains: clinical utility, barriers to implementation, and strategies for national expansion. IUS is positioned to become an increasingly important component of treat-to-target IBD care in Canada, but its equitable and sustainable adoption will require coordinated attention to training, quality, infrastructure, and health-system value.

    2026
    引用
    AI阅读
    加入学术空间
    2Assessing Open-Source Vision-Language Models for Colorectal Polyp Sizing Compared with Endoscopists
    Eric Cristea, Nikoo Mashayekhi, Claire Gefflot, Mira Kandlikar-Bloch, Victoire Michal, Luca di Stefano,Cesare Hassan, Douglas K Rex,Alan Barkun, Roupen Djinbachian,Neal Shahidi, Samir C Grover,

    Abstract Background Accurate colorectal polyp measurement is essential as it guides surveillance intervals and colorectal cancer risk assessment. Emerging vision-language models (VLMs) can estimate polyp size from endoscopic images, but their performance remains unclear. This study compared accuracy of VLMs for colorectal polyp size estimation. Methods In a single-center prospective study, patients ≥18 years undergoing routine colonoscopy were enrolled in an endoscopic video databank. Polyps were resected and measured ex vivo using on-site microscopy, serving as reference standard. Expert endoscopists provided real-time visual estimation. Still images for each polyp were analyzed by 4 VLMs for size estimation. Identical images were then presented to blinded expert endoscopists for size estimation. Primary outcome was correct classification across clinically relevant size categories (diminutive ≤5 mm, small 5.001-9.999 mm, large ≥10 mm) and secondary outcomes included continuous size estimation accuracy. Results For 132 polyps from 85 patients (78.0% diminutive, 21.2% small, 0.8% large), real-time expert visual estimation achieved highest correct size classification (86.0%; 95% CI 78.8-91.1) followed by non-real-time visual estimation (75.4%; 95% CI 70.0-80.1). Performance among the VLMs was variable (ranging from 70.6%; 95% CI 61.5-78.3 to 23.6% 95% CI 16.7-32.2). Three models (Llama4, Qwen3-VL, Mistral-small3.2) demonstrated categorical classification accuracy not statistically different from non-real-time expert assessment. Conclusion Expert endoscopist assessment achieved highest accuracy for clinically relevant polyp size categorization. While current off-the-shelf VLMs are not ready for routine polyp sizing, several models performed similarly to non-real-time expert estimation, suggesting targeted domain-specific training and calibration may enable future AI systems to assist endoscopists with polyp sizing.

    2026
    引用
    AI阅读
    加入学术空间
    3Effect of Bowel Preparation Quality on Colonoscopic Lesion Detection Using Computer-Aided Detection and Mucosal Exposure Devices
    Sacha Mitchell, Victoire Michal,Alan Barkun, Douglas K Rex,Cesare Hassan,Prateek Sharma,Michael B Wallace, Roupen Djinbachian, Megan Oleksiw, Eric Cristea, Chelssy Guerine Ingabire,Edgard Medawar,

    Abstract Background The impact of bowel preparation on outcomes of computer-aided detection (CADe) and mucosal exposure devices (MEDs) is unknown. We examined the association between Boston Bowel Preparation Scale (BBPS) score, CADe use, MED use, and colonoscopic detection metrics in a large real-world cohort. Methods This was a retrospective secondary analysis of a prospective observational cohort at a single academic center (2021-2025). Patients aged ≥45 undergoing elective colonoscopy were included. Adenoma detection rate (ADR), advanced ADR (AADR), sessile serrated lesion detection rate (SSLDR), and adenomas per colonoscopy (APC) were modeled using generalized linear models with piecewise BBPS (threshold 5), withdrawal time, CADe use, MED use, and clinical covariates. Results Three thousand six hundred and sixty-one (3661) patients were included (mean age 65, 51.2% female; 38.4% CADe-assisted, 17.5% MED-assisted). From BBPS 0 to 5, detection improved numerically with increasing preparation quality. Above BBPS 5, no further improvement was observed; AADR and APC declined significantly (odds ratio [OR] 0.63, 95% CI 0.19-0.89; risk ratio [RR] 0.66, 0.46-0.93, respectively). ADR and SSLDR declines were not significant. CADe and MED were independently associated with higher detection across all BBPS levels (eg, ADR at BBPS 5: CADe-assisted 38.4% vs unassisted 28.6%; MED-assisted 38.7% vs 28.6%). MED nearly doubled SSLDR (OR 1.97, 1.38-2.81); CADe did not significantly improve SSLDR (OR 1.21, 0.87-1.67). The benefit of CADe and MED appeared consistent across all preparation categories. Conclusions Adequate, rather than excellent, preparation, is critical to achieve detection thresholds. CADe and MED consistently improved lesion detection across all BBPS scores, supporting their routine use. Clinical Trial Registration ClinicalTrials.gov NCT06822816.

    2026
    引用
    AI阅读
    加入学术空间
    4Effectiveness of Vedolizumab to Reduce Bowel Urgency in a Canadian Real-World Inflammatory Bowel Disease Cohort
    Parul Tandon,Yvette Leung,Ryan Ward, Abhinav Wadhwa,Jessica Weiss, Ruth Moulson,Christopher Pettengell,Robert Battat

    Abstract Background and Aims Bowel urgency is a burdensome symptom of inflammatory bowel disease (IBD) that greatly impacts quality of life. This study evaluated vedolizumab effectiveness on bowel urgency in Canadian patients with ulcerative colitis (UC) and Crohn’s disease (CD). Methods Adults with moderately to severely active UC or CD with baseline Urgency Numeric Rating Scale (UNRS) scores enrolled in the Canadian Patient Support Program (July 2024–March 2025) were included. Bowel urgency and clinical endpoints were evaluated at 2, 6, and 14 weeks. Clinically meaningful improvement (CMI) was defined as UNRS change from baseline ≥3 among patients with baseline UNRS ≥3. UC clinical remission was defined as pM (partial Mayo) score <3. CD clinical response was defined as Harvey-Bradshaw Index (HBI) decrease ≥3 and ≥25% from baseline; remission as HBI <5. Results Of 412 vedolizumab-treated patients (319 UC, 93 CD), most were bio-naïve (UC: 89%, CD: 63%) with median disease durations of 4 years (UC) and 7 years (CD). At baseline, 268 (84%) UC and 74 (80%) CD patients had UNRS ≥3. Median time to CMI was 6 weeks in both cohorts. By week 14, UC patients experienced a 5-point median UNRS reduction (80%) and CD patients a 4-point reduction (62%). Patients achieving CMI at weeks 6 and 14 were significantly more likely to achieve clinical remission. Week 2 urgency outcomes were significant predictors of later outcomes. Conclusions Most UC and CD patients achieved CMI by 6 weeks. CMI was significantly associated with validated clinical outcomes, demonstrating real-world effectiveness of vedolizumab in reducing bowel urgency.

    2026
    引用
    AI阅读
    加入学术空间
    5Taking a Pragmatic Approach to Implement Colonoscopy Quality at a Health System Level: Ontario’s Colonoscopy Quality Strategy
    Catherine Dubé, Akua Kyei, Andrea Hatvani,Meghan Walker, Julia Gao, Jane Ahn,David Morgan, Nancy N Baxter,Linda Rabeneck,Jill Tinmouth

    Abstract Objectives To describe Ontario’s colonoscopy quality strategy (OCQS), to review outcomes to date, to assess it against the Health Quality Ontario framework, and to identify areas for improvement. Methods We provide a descriptive analysis of the OCQS, tracing its development from the launch of the ColonCancerCheck program in 2007 through subsequent initiatives, including funding mechanisms, evidence-based standards, systematic data collection, provider-level performance reporting and feedback. The impact of the OCQS is assessed via temporal trends in colonoscopy quality indicators. Results The OCQS has evolved into a multipronged, system-wide strategy emphasizing evidence generation, collaboration with clinical leaders, and embedding quality improvement within regional cancer programs. Key achievements include standardized reporting, provincial and regional accountability structures, and integration of quality metrics into practice. Over time, there has been improvement in colonoscopy and screening indicators, reflecting the impact of the OCQS. Challenges include addressing endoscopists with persistent performance issues, optimizing accountability mechanisms, and sustaining engagement in a resource-constrained system. Conclusions Ontario’s experience demonstrates that implementing colonoscopy quality initiatives within a complex health system requires pragmatism, iterative refinement, and continuous evaluation. Lessons learned may inform other jurisdictions in designing and scaling endoscopy quality strategies.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 3434 篇论文

    高被引作者

    作者引用发文
    Gil Kaplan151864
    Charles Bernstein1309106
    Alain Bitton130655
    Sanjay Murthy121949
    Coward Stephanie108351
    Eric Benchimol102693
    Joseph W. Windsor99836
    Geoffrey Nguyen90560
    Kuenzig Ellen89962
    Kate Lee71720

    高产作者

    作者引用发文
    Charles Bernstein1309106
    Eric Benchimol102693
    Remo Panaccione52793
    Laura Targownik53080
    Elena Verdu24477
    Premysl Bercik25075
    Karen I. Kroeker12870
    Harminder Singh57865
    Gil Kaplan151864
    Samir Chandra Grover20464

    相关期刊

    Current Gastroenterology Reports
    Frontline gastroenterology
    BMJ open gastroenterology
    Gastroenterology insights
    Crohn's & colitis 360
    Intestinal Research
    Journal of Clinical Gastroenterology
    Gastroenterologia y Hepatologia
    Current Treatment Options in Gastroenterology
    CROHNS & COLITIS 360